Traditional chinese medicine-based network pharmacology could lead to new multicompound drug discovery

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Li, Jian ^a   Lu, Cheng ^b   Jiang, Miao ^b   Niu, Xuyan ^b   Guo, Hongtao ^b   Li, Li ^b   Bian, Zhaoxiang ^c   Lin, Na ^b   Lu, Aiping ^b,c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ASARICIN; ASARININ; CHINESE DRUG; CINNAMALDEHYDE; CINNAMIC ACID; FUZILINE; HIGENAMINE; INDIRUBIN; IRINOTECAN; METHOTREXATE; METHYLEUGENOL; PANAX NOTOGINSENG EXTRACT; PHY 906; REALGAR INDIGO NATURALIS; SAFROLE; SALAZOSULFAPYRIDINE; SALVIA MILTIORRHIZA EXTRACT; SHEXIANGBAOXIN PILL; TANSHINONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOINFORMATICS; CANCER CHEMOTHERAPY; CHINESE MEDICINE; DRUG FORMULATION; DRUG RESEARCH; DRUG SYNTHESIS; DRUG TARGETING; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LEUKEMIA; NONHUMAN; PANAX NOTOGINSENG; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SALVIA MILTIORRHIZA;

EID: 84872149806     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/149762     Document Type: Review

References (58)

1. Hood L., Heath J. R., Phelps M. E., Lin B., Systems biology and new technologies enable predictive and preventative medicine. Science 2004 306 640 643 (Pubitemid 39440903)
2. Goh K. I., Cusick M. E., Valle D., Childs B., Vidal M., Barabasi A. L., The human disease network. Proceedings of the National Academy of Sciences of the United States of America 2007 104 8685 8690 (Pubitemid 47175372)
3. Pawson T., Linding R., Network medicine. FEBS Letters 2008 582 1266 1270
4. Yildirim M. A., Goh K. I., Cusick M. E., Barabasi A. L., Vidal M., Drug-target network. Nature Biotechnology 2007 25 1119 1126 (Pubitemid 47538114)
5. Wermuth C. G., Multitargeted drugs: the end of the "one-target-one- disease" philosophy? Drug Discovery Today 2004 9 19 826 827 2-s2.0-4644289587 10.1016/S1359-6446(04)03213-1 (Pubitemid 39286093)
6. Hopkins A. L., Network pharmacology. Nature Biotechnology 2007 25 1110 1111 (Pubitemid 47538107)
7. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 682 690
8. Sams-Dodd F., Target-based drug discovery: is something wrong? Drug Discovery Today 2005 10 2 139 147 2-s2.0-13844276627 10.1016/S1359-6446(04) 03316-1 (Pubitemid 40247812)
9. Wang Y., Fan X., Qu H., Gao X., Cheng Y., Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Current Topics in Medicinal Chemistry 2012 12 12 1356 1362
10. Lan K., Jia W., An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation. Current Drug Metabolism 2010 11 105 114
11. Tian X. Y., Liu L., Drug discovery enters a new era with multi-target intervention strategy. Chinese Journal of Integrative Medicine. In press 10.1007s11655-011-0900-2
12. Jaques H., The polypill concept: the future. European Heart Journal 2011 32 2732 2733
13. Carey K. M., Comee M. R., Donovan J. L., Kanaan A., A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. The Annals of Pharmacotherapy 2012 46 688 695
14. Lu A., Jiang M., Zhang C., Chan K., An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. Journal of Ethnopharmacology 2011 141 2 549 556
15. Lu A. P., Chen K. J., Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment. Chinese Journal of Integrative Medicine 2009 15 2, article 152
16. He Y. T., Zha Q. L., Yu J. P., Tan Y., Lu C., Lu A. P., Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine 2008 6 32 36 (Pubitemid 351166462)
17. Huang C. H., Cong L., Xie J., Qiao B., Lo S. H., Zheng T., Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes. BMC Proceedings 2009 3 supplement 7 S75
18. Wu G., Zhu L., Dent J. E., Nardini C., A comprehensive molecular interaction map for rheumatoid arthritis. PLoS ONE 2010 5 e10137
19. Zhao J., Jiang P., Zhang W., Molecular networks for the study of TCM pharmacology. Briefings in Bioinformatics 2010 11 417 430
20. Lu C., Niu X., Xiao C., Network-based gene expression biomarkers for cold and heat patterns of rheumatoid arthritis in traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 17 203043 10.1155/2012/203043
21. Chen G., Lu C., Zha Q., A network-based analysis of traditional Chinese medicine cold and hot patterns in rheumatoid arthritis. Complementary Therapies in Medicine 2012 20 23 30
22. Jiang M., Xiao C., Chen G., Correlation between cold and hot pattern in traditional Chinese medicine and gene expression profiles in rheumatoid arthritis. Frontiers of Medicine 2011 5 219 228
23. Lu C., Xiao C., Chen G., Jiang M., Zha Q., Yan X., Kong W., Lu A., Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell. Rheumatology International 2012 32 1 61 68 2-s2.0-77954812917 10.1007/s00296-010-1546-7
24. Gu Y., Lu C., Zha Q., Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry. Molecular BioSystems 2012 8 1535 1543
25. van Wietmarschen H., Yuan K., Lu C., Gao P., Wang J., Xiao C., Yan X., Wang M., Schroën J., Lu A., Xu G., Van Der Greef J., Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. Journal of Clinical Rheumatology 2009 15 7 330 337 2-s2.0-70350152573 10.1097/RHU.0b013e3181ba3926
26. Ma T., Tan C., Zhang H., Wang M., Ding W., Li S., Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Molecular BioSystems 2010 6 613 619
27. Li S., Zhang Z. Q., Wu L. J., Zhang X. G., Li Y. D., Wang Y. Y., Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Systems Biology 2007 1 51 60 (Pubitemid 46779218)
28. Chen M., Zhao L., Jia W., Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. Journal of Proteome Research 2005 4 2391 2396 (Pubitemid 41814313)
29. Lam W., Bussom S., Guan F., Jiang Z., Zhang W., Gullen E. A., Liu S. H., Cheng Y. C., Chemotherapy: the four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Science Translational Medicine 2010 2 45 45ra59 2-s2.0-77955898834 10.1126/scitranslmed.3001270
30. Wang L., Zhou G. B., Liu P., Song J. H., Liang Y., Yan X. J., Xu F., Wang B. S., Mao J. H., Shen Z. X., Chen S. J., Chen Z., Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2008 105 12 4826 4831 2-s2.0-42449161986 10.1073/pnas.0712365105 (Pubitemid 351753831)
31. Jiang P., Dai W., Yan S., Chen Z., Xu R., Ding J., Xiang L., Wang S., Liu R., Zhang W., Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application. Molecular BioSystems 2011 7 3 824 831 2-s2.0-79951651095 10.1039/c0mb00110d
32. Li S., Zhang B., Jiang D., Wei Y., Zhang N., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010 11 11, article S6 2-s2.0-78650832745 10.1186/1471-2105-11-S11-S6
33. van der Greef J., McBurney R. N., Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nature Reviews Drug Discovery 2005 4 12 961 967 2-s2.0-31144438390 10.1038/nrd1904
34. Zhao L., Nicholson J. K., Lu A., Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional Chinese medicine. Journal of proteome research 2012 11 7 3509 3519 10.1021/pr3001628
35. Zhao S., Iyengar R., Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annual Review of Pharmacology and Toxicology 2012 52 505 521
36. Ye H. Z., Zheng C. S., Xu X. J., Wu M. X., Liu X. X., Potential synergistic and multitarget effect of herbal pair Chuanxiong Rhizome-Paeonia Albifora Pall on osteoarthritis disease: a computational pharmacology approach. Chinese Journal of Integrative Medicine 2011 17 698 703
37. Gao L. B. C., Miao J., Yong T., Aiping L., Functional networks for Salvia miltiorrhiza and Panax notoginseng in combination explored with text mining and bioinformatical approach. Journal of Medicinal Plants Research 2011 5, article 10
38. Chen G., Lu A. P., Prediction of the mechanisms of salvia miltiorrhiza against atherosclerosis using text mining and network-based analysis. Journal of Algorithms and Computational Technology 2011 5 1 139 144 2-s2.0-79952844330 10.1260/1748-3018.5.1.139
39. http://www.ncbi.nlm.nih.gov/pubchem
40. Chen B., Wild D., Guha R., PubChem as a source of polypharmacology. Journal of Chemical Information and Modeling 2009 49 9 2044 2055 2-s2.0-70349914727 10.1021/ci9001876
41. Li Q., Cheng T., Wang Y., Bryant S. H., PubChem as a public resource for drug discovery. Drug Discovery Today 2010 15 23-24 1052 1057 2-s2.0-78649633211 10.1016/j.drudis.2010.10.003
42. Pouliot Y., Chiang A. P., Butte A. J., Predicting adverse drug reactions using publicly available PubChem bioassay data. Clinical Pharmacology and Therapeutics 2011 90 1 90 99 2-s2.0-79959380528 10.1038/clpt.2011.81
43. Li S., Wu L., Zhang Z., Constructing biological networks through combined literature mining and microarray analysis: a LMMA approach. Bioinformatics 2006 22 17 2143 2150 2-s2.0-33748669610 10.1093/bioinformatics/btl363 (Pubitemid 44390906)
44. Le Phillip P., Bahl A., Ungar L. H., Using prior knowledge to improve genetic network reconstruction from microarray data. In Silico Biology 2004 4 3 335 353 2-s2.0-10044240790 (Pubitemid 39600480)
45. van der Greef J., McBurney R. N., Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nature Reviews Drug Discovery 2005 4 12 961 967 2-s2.0-31144438390 10.1038/nrd1904
46. Ideker T., Galitski T., Hood L., A new approach to decoding life: systems biology. Annual Review of Genomics and Human Genetics 2001 2 343 372 (Pubitemid 35265011)
47. Kitano H., Computational systems biology. Nature 2002 420 206 210 (Pubitemid 35340131)
48. Adams C. P., Brantner V. V., Estimating the cost of new drug development: is it really 802 million dollars? Health Affairs 2006 25 420 428 (Pubitemid 43529550)
49. Dickson M., Gagnon J. P., The cost of new drug discovery and development. Discovery Medicine 2004 4 172 179
50. Kola I., Landis J., Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery 2004 3 8 711 715 2-s2.0-4344645978 (Pubitemid 39173511)
51. Kaitin K. I., Obstacles and opportunities in new drug development. Clinical Pharmacology and Therapeutics 2008 83 210 212
52. Ashburn T. T., Thor K. B., Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery 2004 3 8 673 683 2-s2.0-4344668661 (Pubitemid 39173508)
53. Chen Y. Z., Zhi D. G., Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 2001 43 217 226
54. Li Y. Y., An J., Jones S. J., A large-scale computational approach to drug repositioning. Genome Informatics 2006 17 2 239 247
55. Dubus E., Ijjaali I., Barberan O., Petitet F., Drug repositioning using in silico compound profiling. Future Medicinal Chemistry 2009 1 9 1723 1736 2-s2.0-77953387346 10.4155/fmc.09.123
56. Lu C., Zha Q., Chang A., He Y., Lu A., Pattern differentiation in Traditional Chinese Medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis. Journal of Alternative and Complementary Medicine 2009 15 1021 1025
57. Lu C., Xiao C., Chen G., Jiang M., Zha Q., Yan X., Kong W., Lu A., Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell. Rheumatology International 2010 1 8 2-s2.0-77954812917 10.1007/s00296-010-1546-7
58. Miao Jiang C. L., Chen G., Xiao C., Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 129452 10.1155/2012/129452